De-Sheng Weng

Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma

Ke Pan, Hui Wang, Min-Shan Chen et al. · Journal of Cancer Research and Clinical Oncology · 2008 · 172 citations · Full text

Medicine, Cancer Biology, Oncology +13

Minimally Invasive Treatment Combined With Cytokine-induced Killer Cells Therapy Lower the Short-term Recurrence Rates of Hepatocellular Carcinomas

De-Sheng Weng, Jun Zhou, Qi-Ming Zhou et al. · Journal of Immunotherapy · 2008 · 155 citations

Medicine, Immunology, Oncology +17

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma

Shan-Shan Jiang, Yan Tang, Yaojun Zhang et al. · Oncotarget · 2015 · 111 citations · Full text

Medicine, Cancer Biology, Oncology +17

IL-17A Promotes Immune Cell Recruitment in Human Esophageal Cancers and the Infiltrating Dendritic Cells Represent a Positive Prognostic Marker for Patient Survival

Lin Lü, Ke Pan, Haixia Zheng et al. · Journal of Immunotherapy · 2013 · 104 citations

Life Sciences, Immunology, Oncology +17

Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells

Jing-Jing Zhao, Qiu-Zhong Pan, Ke Pan et al. · Scientific Reports · 2014 · 103 citations · Full text

Life Sciences, Immunology, Oncology +16